{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:12:40Z","timestamp":1721229160888},"reference-count":29,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14474","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T12:26:21Z","timestamp":1716899181000},"source":"Crossref","is-referenced-by-count":0,"title":["Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma\u2011not otherwise specified: A case report"],"prefix":"10.3892","volume":"28","author":[{"given":"Heng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistic Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistic Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistic Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistic Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The 940th Hospital of Joint Logistic Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistic Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"key20240717175752_b1-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.3324\/haematol.2023.282716","article-title":"Pathobiology of nodal peripheral T-cell lymphomas: Current understanding and future directions","volume":"108","author":"Bisig","year":"2023","journal-title":"Haematologica"},{"key":"key20240717175752_b2-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: A report of 340 cases from the international peripheral T-cell lymphoma project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"key20240717175752_b3-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ajh.25513","article-title":"Aggressive T-cell lymphomas: 2019 Updates on diagnosis, risk stratification, and management","volume":"94","author":"Zain","year":"2019","journal-title":"Am J Hematol"},{"key":"key20240717175752_b4-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00259-012-2320-8","article-title":"Interim FDG PET\/CT as a prognostic factor in diffuse large B-cell lymphoma","volume":"40","author":"Fuertes","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key20240717175752_b5-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20240717175752_b6-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: Pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20240717175752_b7-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: A proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20240717175752_b8-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic therapies for cancer","volume":"383","author":"Bates","year":"2020","journal-title":"N Engl J Med"},{"key":"key20240717175752_b9-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.3390\/cimb45110563","article-title":"The role of epigenetic modifier mutations in peripheral T-cell lymphomas","volume":"45","author":"Tigu","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"key20240717175752_b10-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"key20240717175752_b11-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"key":"key20240717175752_b12-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12185-016-2122-z","article-title":"Dysregulation of TET2 in hematologic malignancies","volume":"105","author":"Chiba","year":"2017","journal-title":"Int J Hematol"},{"key":"key20240717175752_b13-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/bcj.2014.83","article-title":"Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice","volume":"4","author":"Muto","year":"2014","journal-title":"Blood Cancer J"},{"key":"key20240717175752_b14-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/leu.2013.337","article-title":"The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases","volume":"28","author":"Solary","year":"2014","journal-title":"Leukemia"},{"key":"key20240717175752_b15-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41467-019-09541-y","article-title":"Loss of TET2 and TET3 in regulatory T cells unleashes effector function","volume":"10","author":"Yue","year":"2019","journal-title":"Nat Commun"},{"key":"key20240717175752_b16-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"e1006334","DOI":"10.1371\/journal.pgen.1006334","article-title":"Dnmt3a is a haploinsufficient tumor suppressor in CD8+ peripheral T cell lymphoma","volume":"12","author":"Haney","year":"2016","journal-title":"PLoS Genet"},{"key":"key20240717175752_b17-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"key20240717175752_b18-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"key":"key20240717175752_b19-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood.V124.21.1635.1635","article-title":"Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: A study from the Swedish lymphoma registry","volume":"124","author":"Ellin","year":"2014","journal-title":"Blood"},{"key":"key20240717175752_b20-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d'Amore","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20240717175752_b21-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/cncr.31861","article-title":"The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study","volume":"125","author":"Park","year":"2019","journal-title":"Cancer"},{"key":"key20240717175752_b22-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-cell lymphoma after first relapse or progression: Spectrum of disease and rare long-term survivors","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20240717175752_b23-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/ajh.24992","article-title":"Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL)","volume":"93","author":"Zhang","year":"2018","journal-title":"Am J Hematol"},{"key":"key20240717175752_b24-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1182\/bloodadvances.2021004269","article-title":"Impact of comorbidity in older patients with peripheral T-cell lymphoma: An international retrospective analysis of 891 patients","volume":"6","author":"Mead","year":"2022","journal-title":"Blood Adv"},{"key":"key20240717175752_b25-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","article-title":"Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma","volume":"26","author":"Shi","year":"2015","journal-title":"Ann Oncol"},{"key":"key20240717175752_b26-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1182\/blood-2018-04-840538","article-title":"Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma","volume":"132","author":"Lemonnier","year":"2018","journal-title":"Blood"},{"key":"key20240717175752_b27-ol-28-2-14474","first-page":"2194","article-title":"Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL","volume":"141","author":"Ruan","year":"2023","journal-title":"Blood"},{"key":"key20240717175752_b28-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1182\/blood.2020009004","article-title":"Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: A multicenter phase 2 study","volume":"137","author":"Falchi","year":"2021","journal-title":"Blood"},{"issue":"(S3)","key":"key20240717175752_b29-ol-28-2-14474","doi-asserted-by":"publisher","first-page":"e7508938","DOI":"10.1097\/01.HS9.0000975964.75089.38","article-title":"PB2310: Chidamide with azacitidine and chop treatment for patients with newly diagnosed peripheral T-cell lymphoma: Interim analysis of a prospective, single center, single-arm, phase 2 trial","volume":"7","author":"Xiao","year":"2023","journal-title":"HemaSphere"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T14:57:59Z","timestamp":1721228279000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14474","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"article-number":"341"}}